Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
AffiliationUniversity Department of Medicine and Pharmacy, Hope Hospital, Salford.
MetadataShow full item record
CitationSclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma. 1988, 297 (6651):772-3 BMJ
- Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.
- Authors: Glover D, Lipton A, Keller A, Miller AA, Browning S, Fram RJ, George S, Zelenakas K, Macerata RS, Seaman JJ
- Issue date: 1994 Dec 1
- [Disodium pamidronate (APD) in the treatment of bone metastases].
- Authors: Costa L, Moreira C, da Costa EB
- Issue date: 1993 Feb
- Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
- Authors: Dodwell DJ, Howell A, Ford J
- Issue date: 1990 Jan
- Pain relief and sclerosis of bone metastases in a patient with breast cancer treated with tamoxifen, radiotherapy and pamidronate disodium: which treatment helped?
- Authors: Ripamonti C, Fulfaro F, Polastri D, De Conno F, Laffranchi A, Moliterni A
- Issue date: 1998 Aug
- Efficacy of pamidronate in breast cancer with bone metastases: a randomized double-blind placebo controlled multicenter study.
- Authors: Hultborn R, Gundersen S, Rydén S, Holmberg E, Carstensen J, Wallgren UB, Kilany S
- Issue date: 1996